Robin Sherrington
Corporate Officer/Principal bij XENON PHARMACEUTICALS INC.
Vermogen: 361 534 $ op 31-03-2024
Profiel
Robin Sherrington currently works at Xenon Pharmaceuticals, Inc., as Executive Vice President-Strategy & Innovation from 2019.
Dr. Sherrington also formerly worked at Pfizer Inc., as Neuroscience Director from 1999 to 2001, Sequana Therapeutics, Inc., as Neuroscience Director from 1996 to 1999, Axys Pharmaceuticals, Inc., as Neuroscience Director from 1996 to 1999, and Parke-Davis & Co. Ltd., as Neuroscientist.
Dr. Sherrington received his undergraduate degree from The University of Reading and doctorate degree from University College London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-03-2024 | 8 398 ( 0.01% ) | 361 534 $ | 31-03-2024 |
Actieve functies van Robin Sherrington
| Bedrijven | Functie | Begin |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-03-2019 |
Eerdere bekende functies van Robin Sherrington
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2001 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-1999 |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Corporate Officer/Principal | 01-01-1999 |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Opleiding van Robin Sherrington
| The University of Reading | Undergraduate Degree |
| University College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Health Technology |
